This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Jun;3(3):140-142.

doi: 10.1089/crispr.2020.29094.yzh.

CRISPR-Cas13 as an Antiviral Strategy for Coronavirus Disease 2019

Yan Zhang¹

Affiliations

PMID: 33560913
DOI: 10.1089/crispr.2020.29094.yzh

Comment

CRISPR-Cas13 as an Antiviral Strategy for Coronavirus Disease 2019

Yan Zhang. CRISPR J. 2020 Jun.

. 2020 Jun;3(3):140-142.

doi: 10.1089/crispr.2020.29094.yzh.

Author

Yan Zhang¹

Affiliation

¹ Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan, USA.

PMID: 33560913
DOI: 10.1089/crispr.2020.29094.yzh

No abstract available

PubMed Disclaimer

Comment on

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
Abbott TR, Dhamdhere G, Liu Y, Lin X, Goudy L, Zeng L, Chemparathy A, Chmura S, Heaton NS, Debs R, Pande T, Endy D, La Russa MF, Lewis DB, Qi LS. Abbott TR, et al. Cell. 2020 May 14;181(4):865-876.e12. doi: 10.1016/j.cell.2020.04.020. Epub 2020 Apr 29. Cell. 2020. PMID: 32353252 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information